Bolt Biotherapeutics, Inc. reported raising $13.4 Million in an initial SEC Form D filing, from an offering of $13.4 Million
Amount Raised
$13.4 Million
Round Type
Venture
Redwood CityOtherBiotechnologyWho else raised in Biotechnology around the same time
Companies in the same sectors as Bolt Biotherapeutics that raised within 45 days of this round, from Fundz verified event records.
- ARS Pharmaceuticals, Inc. raised $12M on September 20, 2018.
- Elysium Therapeutics raised $932K on September 20, 2018.
- Ambient Biosciences raised $7M on September 20, 2018.
- Atreca, Inc. raised $125M on September 19, 2018.
- Specialty Renal Products, Inc. raised $3M (Seed) on September 18, 2018.
- RECOMBINETICS, INC raised $34M on September 18, 2018.
Who to call at Bolt Biotherapeutics, and when
A new round usually means Bolt Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Bolt Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bolt Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bolt Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bolt Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Bolt Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.